The Patent Finder
US

Oral Cannabinoid Formulations

US 10,265,293 In force
OverviewFamilyAssignmentsSources & methods

Term ends Aug 6, 2028 · High confidence

Filed Apr 19, 2016 as application 15/132,896 · Granted Apr 23, 2019
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
20 years from filing
2012 2032
Clock starts
Oct 4, 2012
Term ends
Aug 6, 2028
Granted
Apr 23, 2019
base term after the term ends fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,222,292, US 9,345,771.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
23
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 4, 2012, when application 13/644,283, the earliest non-provisional in its chain, was filed (this one was filed Apr 19, 2016)Oct 4, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,222,292, US 9,345,771)capped to Aug 6, 2028High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 6, 2028High confidence

This family

US 9,345,771In force
Aug 2028
Aug 2028
US 11,224,660In force
May 2035
May 2035
US 11,331,279In force
May 2035
May 2035
US 9,662,334In force
Nov 2034
Nov 2034
US 10,265,293this patent
Aug 2028
Aug 2028
Application 15/166,476Pending
not computed
not computed
Application PCT/US2016/034565PCT application
no patent term
no patent term
US 10,172,833In force
Nov 2034
Nov 2034
8 of 23 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 6, 2019
Reel 50296, frame 736
Goskonda, Venkat R.; Chavan, Ashok; Gill, HowardInsys Development Company, Inc.Assignment of Assignor's Interest
Dec 2, 2019
Reel 51152, frame 366
Insys Development Company, Inc.; Insys Pharma, Inc.; Insys Therapeutics, Inc.Fresh Cut Development, LLCAssignment of Assignor's Interest
Dec 2, 2019
Reel 51152, frame 396
Fresh Cut Development, LLCBenuvia Therapeutics Inc.Assignment of Assignor's Interest
Dec 19, 2019
Reel 51381, frame 283
Benuvia Therapeutics Inc.Fresh Cut Development, LLCAssignment of Assignor's Interest
Feb 12, 2021
Reel 55246, frame 668
Fresh Cut Development, LLCBenuvia Therapeutics, LLCAssignment of Assignor's Interest
Jul 21, 2021
Reel 56936, frame 429
Goskonda, Venkat R; Kokate, Amit; Chavan, Ashok; Gill, HowardInsys Pharma, Inc.Assignment of Assignor's Interest
Jul 21, 2021
Reel 56936, frame 484
Insys Therapeutics, Inc.; Insys Pharma, Inc.; Insys Development Company, Inc.Fresh Cut Development, LLCAssignment of Assignor's Interest
Jul 21, 2021
Reel 56936, frame 539
Fresh Cut Development, LLCBenuvia Therapeutics, LLCAssignment of Assignor's Interest
Aug 27, 2021
Reel 57649, frame 166
Fresh Cut Development, LLCBenuvia Therapeutics, LLCCorrective Assignment to Correct the List of Application Numbers Previously Recorded at Reel: 055246 Frame: 0668. Assignor(S) Hereby Confirms the Assignment .
Dec 8, 2021
Reel 58340, frame 146
Benuvia Therapeutics, LLCJupiter Wellness, Inc.Security Interest
Sep 23, 2022
Reel 61190, frame 393
Benuvia Therapeutics, LLCBenuvia Operations, LLCAssignment of Assignor's Interest
Mar 12, 2025
Reel 70482, frame 222
Benuvia Operations, LLCWellhouse Pharma, LLCAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited